Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
10/15/1997 | CN1161967A Preparation method for imidazole derivatives |
10/15/1997 | CN1161957A Method for separating tramadol raceme |
10/15/1997 | CN1161834A Prepration method for medicinal composition containing triazolyl derivative |
10/14/1997 | US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase |
10/14/1997 | US5677348 Substituted aminoguanidines and methods of use thereof |
10/14/1997 | US5677344 Administering a sulfonyl urea or quinine |
10/14/1997 | US5677328 Ethylamino carbazole melatonergic agents |
10/14/1997 | US5677325 Administering as partial agonist of the glycine b site; for treatment of convulsion, alzheimer's disease, huntingtons's chorea, anxiety |
10/14/1997 | US5677324 Benzopyranes as potassium channel openers |
10/14/1997 | US5677321 Anesthetic premedication |
10/14/1997 | US5677319 Thiazole derivative |
10/14/1997 | US5677313 Antipsychotic method |
10/14/1997 | US5677311 Serotonin antagonism and acetylcholine release accelerating action; antiemetic and oxiolytic agent |
10/14/1997 | US5677310 Hypertensive agents, migraine |
10/14/1997 | US5677306 Antagonizing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, useful for treating all ischemias |
10/14/1997 | US5677281 Use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16 |
10/14/1997 | US5677277 Brain disorders |
10/14/1997 | US5676970 Anti-inflammatory analgesic plaster |
10/14/1997 | US5676965 Use of polydeoxyribonucleotides in diabetic neuropathies |
10/14/1997 | US5676943 Nerve growth factor |
10/14/1997 | US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor |
10/14/1997 | US5676831 Isoindolinone derivative, preparation thereof and pharmaceutical compositions containing same |
10/14/1997 | CA2090423C Method of preparing diacetyl rhein |
10/14/1997 | CA2075869C Production of fluoxetine and new intermediates |
10/12/1997 | CA2202425A1 A novel anti-spasmodic and antiinflammatory composition and a process for the manufacture thereof |
10/09/1997 | WO1997037228A1 Methods for diagnosing and treating alzheimer's disease |
10/09/1997 | WO1997037043A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
10/09/1997 | WO1997037026A1 Novel compounds |
10/09/1997 | WO1997037002A1 Promotion of regeneration of organized tissues |
10/09/1997 | WO1997036923A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
10/09/1997 | WO1997036919A2 Cytokine designated lerk-8 |
10/09/1997 | WO1997036907A1 Benzoxazines for enhancing synaptic response |
10/09/1997 | WO1997036906A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | WO1997036893A1 Piperazine and piperidine compounds |
10/09/1997 | WO1997036871A1 6-phenylpyridyl-2-amine derivatives |
10/09/1997 | WO1997036867A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
10/09/1997 | WO1997036853A1 Dimethyl-substituted cyclohexane diene derivatives |
10/09/1997 | WO1997036596A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
10/09/1997 | WO1997036591A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036589A1 Use of 1-benzyl-1,2,3,4-tetrahyhydroisoquinoline for the manufacture of a medicament for improving cerebral function |
10/09/1997 | WO1997036588A2 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain |
10/09/1997 | WO1997036584A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036583A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof |
10/09/1997 | CA2250937A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250843A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | CA2250587A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250154A1 Dimethyl-substituted cyclohexane diene derivatives |
10/09/1997 | CA2250143A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249603A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
10/09/1997 | CA2248729A1 Promotion of regeneration of organized tissues |
10/09/1997 | CA2247996A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q |
10/09/1997 | CA2201988A1 Heterocyclic .beta.-adrenergic agonists |
10/08/1997 | EP0799819A1 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity |
10/08/1997 | EP0799314A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES |
10/08/1997 | EP0799231A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents |
10/08/1997 | EP0799226A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists |
10/08/1997 | EP0799225A1 Compounds and methods |
10/08/1997 | EP0799218A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
10/08/1997 | EP0799206A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
10/08/1997 | EP0799200A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
10/08/1997 | EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
10/08/1997 | EP0799056A1 Use of a tachykinin antagonist and an opioid analgesic |
10/08/1997 | EP0799045A1 New method of treatment |
10/08/1997 | EP0799041A1 Estrogen compositions and method for neuroprotection |
10/08/1997 | EP0799040A1 Trisubstituted thioxanthines |
10/08/1997 | EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
10/08/1997 | EP0799034A1 Treatment of movement disorders using large neutral amino acids |
10/08/1997 | EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
10/08/1997 | CN1161696A Heterocycle substituted propenoic acid derivatives as NMDA antagonists |
10/08/1997 | CN1161647A Compositions and method for controlling smoking |
10/08/1997 | CN1036064C Method for preparing benzene derivatives with activity for improving the growth of NGF |
10/07/1997 | US5675027 Intermediates for making 4- (2-benzothiazolyl)methylamino!-α- (3, 4-difluorophenoxy)methyl!-1-piperidineethanol |
10/07/1997 | US5675008 Excitatory amino acid receptor antagonists |
10/07/1997 | US5675007 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands |
10/07/1997 | US5674998 C-4' modified adenosine kinase inhibitors |
10/07/1997 | US5674890 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them |
10/07/1997 | US5674885 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes |
10/07/1997 | US5674884 For treatment of serotonin-related disorders |
10/07/1997 | US5674881 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
10/07/1997 | US5674880 Tri-substituted phenyl derivatives and processes for their preparation |
10/07/1997 | US5674871 Iontophoretic delivery of an antimigraine drug |
10/07/1997 | US5674868 Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists |
10/07/1997 | US5674862 Methods of treating diabetic mellitus and its complications |
10/07/1997 | US5674487 Method for treating autoimmune diseases |
10/07/1997 | CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation |
10/02/1997 | WO1997035862A1 Azaspiroderivatives |
10/02/1997 | WO1997035861A1 Azaspiro derivatives |
10/02/1997 | WO1997035858A1 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY |
10/02/1997 | WO1997035857A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
10/02/1997 | WO1997035856A1 Novel treatment for cns injuries |
10/02/1997 | WO1997035855A1 Novel treatment for cns injuries |
10/02/1997 | WO1997035846A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
10/02/1997 | WO1997035604A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
10/02/1997 | WO1997035583A1 Method for treating pain |
10/02/1997 | WO1997035582A1 Method for treating migraine pain |
10/02/1997 | WO1997035580A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof |
10/02/1997 | WO1997035578A1 Tetrahydro-beta-carboline compounds |
10/02/1997 | WO1997035577A1 Remedy for spinal injury |
10/02/1997 | WO1997035539A2 Arylamino fused pyridines and pyrimidines |